Article Details

20211014 CSL Reaffirms Commitment to Manufacture AstraZeneca COVID Vaccine into 2022

Retrieved on: 2021-10-13 23:04:33

Tags for this article:

Click the tags to see associated articles and topics

20211014 CSL Reaffirms Commitment to Manufacture AstraZeneca COVID Vaccine into 2022. View article details on HISWAI: https://www.csl.com/news/2021/20211014-csl-reaffirms-commitment-to-manufacture-astrazeneca-covid-vaccine-into-2022

Excerpt

Melbourne, Australia: CSL is committed to the manufacture of approximately 50 million doses of the AstraZeneca COVID-19 vaccine, Vaxzevria.

Article found on: www.csl.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up